Live Quote · NASDAQACRSHealthcare· Biotechnology

Aclaris Therapeutics, Inc.

$3.44▼ 1.71%($-0.06)
MKT CAP $545.63MNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
49/100
▌ Weak
40
Valuation
40
Profitability
55
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACRS research report →

Analyst Price Target
$7.33+113.1% vs. today

Range $3 – $10

Analyst RatingBuy
14 Buy3 Hold0 Sell

Price Chart

+42.74% · this period
$6.54$4.47$2.41Nov 20May 26Nov 20
52-Week Range26% of range
Low
$2.34
Current
$3.44
High
$6.60